"Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients"@en . . . "Roubec, Jarom\u00EDr" . "Hejduk, Karel" . . "Pe\u0161ek, Milo\u0161" . . "[76591EA87601]" . "Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients" . "Povoln\u00E1, Zdenka" . . "In a group of 233 patients with advanced non-squamous NSCLC who were treated with pemetrexed in first line and in combination with cisplatin, the therapy was well tolerated: termination of treatment due to adverse events was reported only in 3.8% of patients. Median overall was 11.6 months, median progression-free survival was 4.2 months."@en . "Zemanov\u00E1, Milada" . . . "Kolek, V\u00EDt\u011Bzslav" . "Koubkov\u00E1, Leona" . . "Havel, Libor" . "RIV/00216224:14110/13:00070496!RIV14-MSM-14110___" . "Sk\u0159i\u010Dkov\u00E1, Jana" . "\u0160at\u00E1nkov\u00E1, Monika" . . . "Salajka, Franti\u0161ek" . "Hrnciarik, Michal" . "14110" . "In a group of 233 patients with advanced non-squamous NSCLC who were treated with pemetrexed in first line and in combination with cisplatin, the therapy was well tolerated: termination of treatment due to adverse events was reported only in 3.8% of patients. Median overall was 11.6 months, median progression-free survival was 4.2 months." . "\u010Coupkov\u00E1, Helena" . "Tom\u00ED\u0161kov\u00E1, Marcela" . "4"^^ . "Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients"@en . "95674" . . "RIV/00216224:14110/13:00070496" . . . "Bortl\u00ED\u010Dek, Zbyn\u011Bk" . "Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients" . . "17"^^ . "\u010Cernovsk\u00E1, Mark\u00E9ta" . . . . "Sixtov\u00E1, Dimka" . "I" . "first-line treatment; NSCLC"@en .